1 Market Overview

1.1 Product Overview and Scope of COVID-19 Medicine

1.2 Classification of COVID-19 Medicine by Type

1.2.1 Overview: Global COVID-19 Medicine Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global COVID-19 Medicine Revenue Market Share by Type in 2020

1.2.3 Tablet

1.2.4 Injection

1.3 Global COVID-19 Medicine Market by Application

1.3.1 Overview: Global COVID-19 Medicine Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Patients With Mild Symptoms

1.3.3 Critically Ill

1.3.4 Other

1.4 Global COVID-19 Medicine Market Size & Forecast

1.5 Global COVID-19 Medicine Market Size and Forecast by Region

1.5.1 Global COVID-19 Medicine Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global COVID-19 Medicine Market Size by Region, (2016-2021)

1.5.3 North America COVID-19 Medicine Market Size and Prospect (2016-2026)

1.5.4 Europe COVID-19 Medicine Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific COVID-19 Medicine Market Size and Prospect (2016-2026)

1.5.6 South America COVID-19 Medicine Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa COVID-19 Medicine Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 COVID-19 Medicine Market Drivers

1.6.2 COVID-19 Medicine Market Restraints

1.6.3 COVID-19 Medicine Trends Analysis

2 Company Profiles

2.1 Advanz Pharma

2.1.1 Advanz Pharma Details

2.1.2 Advanz Pharma Major Business

2.1.3 Advanz Pharma COVID-19 Medicine Product and Solutions

2.1.4 Advanz Pharma COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Advanz Pharma Recent Developments and Future Plans

2.2 Kyung Poong

2.2.1 Kyung Poong Details

2.2.2 Kyung Poong Major Business

2.2.3 Kyung Poong COVID-19 Medicine Product and Solutions

2.2.4 Kyung Poong COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Kyung Poong Recent Developments and Future Plans

2.3 Mylan

2.3.1 Mylan Details

2.3.2 Mylan Major Business

2.3.3 Mylan COVID-19 Medicine Product and Solutions

2.3.4 Mylan COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Mylan Recent Developments and Future Plans

2.4 Novartis

2.4.1 Novartis Details

2.4.2 Novartis Major Business

2.4.3 Novartis COVID-19 Medicine Product and Solutions

2.4.4 Novartis COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Novartis Recent Developments and Future Plans

2.5 Sanofi

2.5.1 Sanofi Details

2.5.2 Sanofi Major Business

2.5.3 Sanofi COVID-19 Medicine Product and Solutions

2.5.4 Sanofi COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Sanofi Recent Developments and Future Plans

2.6 Apotex

2.6.1 Apotex Details

2.6.2 Apotex Major Business

2.6.3 Apotex COVID-19 Medicine Product and Solutions

2.6.4 Apotex COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Apotex Recent Developments and Future Plans

2.7 Bayer

2.7.1 Bayer Details

2.7.2 Bayer Major Business

2.7.3 Bayer COVID-19 Medicine Product and Solutions

2.7.4 Bayer COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Bayer Recent Developments and Future Plans

2.8 Guangzhou Baiyunshan Guanghua Pharmaceutical

2.8.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Details

2.8.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Major Business

2.8.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Product and Solutions

2.8.4 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments and Future Plans

2.9 Ipca Laboratories

2.9.1 Ipca Laboratories Details

2.9.2 Ipca Laboratories Major Business

2.9.3 Ipca Laboratories COVID-19 Medicine Product and Solutions

2.9.4 Ipca Laboratories COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Ipca Laboratories Recent Developments and Future Plans

2.10 Sichuan Sunny Hope

2.10.1 Sichuan Sunny Hope Details

2.10.2 Sichuan Sunny Hope Major Business

2.10.3 Sichuan Sunny Hope COVID-19 Medicine Product and Solutions

2.10.4 Sichuan Sunny Hope COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Sichuan Sunny Hope Recent Developments and Future Plans

2.11 Zydus Cadila

2.11.1 Zydus Cadila Details

2.11.2 Zydus Cadila Major Business

2.11.3 Zydus Cadila COVID-19 Medicine Product and Solutions

2.11.4 Zydus Cadila COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Zydus Cadila Recent Developments and Future Plans

2.12 Teva

2.12.1 Teva Details

2.12.2 Teva Major Business

2.12.3 Teva COVID-19 Medicine Product and Solutions

2.12.4 Teva COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Teva Recent Developments and Future Plans

2.13 Sun Pharma

2.13.1 Sun Pharma Details

2.13.2 Sun Pharma Major Business

2.13.3 Sun Pharma COVID-19 Medicine Product and Solutions

2.13.4 Sun Pharma COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Sun Pharma Recent Developments and Future Plans

2.14 Rising Pharmaceutical

2.14.1 Rising Pharmaceutical Details

2.14.2 Rising Pharmaceutical Major Business

2.14.3 Rising Pharmaceutical COVID-19 Medicine Product and Solutions

2.14.4 Rising Pharmaceutical COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Rising Pharmaceutical Recent Developments and Future Plans

2.15 KPC Group

2.15.1 KPC Group Details

2.15.2 KPC Group Major Business

2.15.3 KPC Group COVID-19 Medicine Product and Solutions

2.15.4 KPC Group COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 KPC Group Recent Developments and Future Plans

2.16 Bristol Laboratories

2.16.1 Bristol Laboratories Details

2.16.2 Bristol Laboratories Major Business

2.16.3 Bristol Laboratories COVID-19 Medicine Product and Solutions

2.16.4 Bristol Laboratories COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Bristol Laboratories Recent Developments and Future Plans

2.17 Shanghai Zhongxisanwei

2.17.1 Shanghai Zhongxisanwei Details

2.17.2 Shanghai Zhongxisanwei Major Business

2.17.3 Shanghai Zhongxisanwei COVID-19 Medicine Product and Solutions

2.17.4 Shanghai Zhongxisanwei COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Shanghai Zhongxisanwei Recent Developments and Future Plans

2.18 Shanghai Pharma

2.18.1 Shanghai Pharma Details

2.18.2 Shanghai Pharma Major Business

2.18.3 Shanghai Pharma COVID-19 Medicine Product and Solutions

2.18.4 Shanghai Pharma COVID-19 Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Shanghai Pharma Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global COVID-19 Medicine Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 COVID-19 Medicine Players Market Share

3.2.2 Top 10 COVID-19 Medicine Players Market Share

3.2.3 Market Competition Trend

3.3 COVID-19 Medicine Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global COVID-19 Medicine Revenue and Market Share by Type (2016-2021)

4.2 Global COVID-19 Medicine Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global COVID-19 Medicine Revenue Market Share by Application (2016-2021)

5.2 COVID-19 Medicine Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America COVID-19 Medicine Revenue by Type (2016-2026)

6.2 North America COVID-19 Medicine Revenue by Application (2016-2026)

6.3 North America COVID-19 Medicine Market Size by Country

6.3.1 North America COVID-19 Medicine Revenue by Country (2016-2026)

6.3.2 United States COVID-19 Medicine Market Size and Forecast (2016-2026)

6.3.3 Canada COVID-19 Medicine Market Size and Forecast (2016-2026)

6.3.4 Mexico COVID-19 Medicine Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe COVID-19 Medicine Revenue by Type (2016-2026)

7.2 Europe COVID-19 Medicine Revenue by Application (2016-2026)

7.3 Europe COVID-19 Medicine Market Size by Country

7.3.1 Europe COVID-19 Medicine Revenue by Country (2016-2026)

7.3.2 Germany COVID-19 Medicine Market Size and Forecast (2016-2026)

7.3.3 France COVID-19 Medicine Market Size and Forecast (2016-2026)

7.3.4 United Kingdom COVID-19 Medicine Market Size and Forecast (2016-2026)

7.3.5 Russia COVID-19 Medicine Market Size and Forecast (2016-2026)

7.3.6 Italy COVID-19 Medicine Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific COVID-19 Medicine Revenue by Type (2016-2026)

8.2 Asia-Pacific COVID-19 Medicine Revenue by Application (2016-2026)

8.3 Asia-Pacific COVID-19 Medicine Market Size by Region

8.3.1 Asia-Pacific COVID-19 Medicine Revenue by Region (2016-2026)

8.3.2 China COVID-19 Medicine Market Size and Forecast (2016-2026)

8.3.3 Japan COVID-19 Medicine Market Size and Forecast (2016-2026)

8.3.4 South Korea COVID-19 Medicine Market Size and Forecast (2016-2026)

8.3.5 India COVID-19 Medicine Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia COVID-19 Medicine Market Size and Forecast (2016-2026)

8.3.7 Australia COVID-19 Medicine Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America COVID-19 Medicine Revenue by Type (2016-2026)

9.2 South America COVID-19 Medicine Revenue by Application (2016-2026)

9.3 South America COVID-19 Medicine Market Size by Country

9.3.1 South America COVID-19 Medicine Revenue by Country (2016-2026)

9.3.2 Brazil COVID-19 Medicine Market Size and Forecast (2016-2026)

9.3.3 Argentina COVID-19 Medicine Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa COVID-19 Medicine Revenue by Type (2016-2026)

10.2 Middle East & Africa COVID-19 Medicine Revenue by Application (2016-2026)

10.3 Middle East & Africa COVID-19 Medicine Market Size by Country

10.3.1 Middle East & Africa COVID-19 Medicine Revenue by Country (2016-2026)

10.3.2 Turkey COVID-19 Medicine Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia COVID-19 Medicine Market Size and Forecast (2016-2026)

10.3.4 UAE COVID-19 Medicine Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global COVID-19 Medicine Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global COVID-19 Medicine Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market COVID-19 Medicine Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global COVID-19 Medicine Revenue (USD Million) by Region (2016-2021)

Table 5. Global COVID-19 Medicine Revenue Market Share by Region (2021-2026)

Table 6. Advanz Pharma Corporate Information, Head Office, and Major Competitors

Table 7. Advanz Pharma Major Business

Table 8. Advanz Pharma COVID-19 Medicine Product and Solutions

Table 9. Advanz Pharma COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Kyung Poong Corporate Information, Head Office, and Major Competitors

Table 11. Kyung Poong Major Business

Table 12. Kyung Poong COVID-19 Medicine Product and Solutions

Table 13. Kyung Poong COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Mylan Corporate Information, Head Office, and Major Competitors

Table 15. Mylan Major Business

Table 16. Mylan COVID-19 Medicine Product and Solutions

Table 17. Mylan COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Novartis Corporate Information, Head Office, and Major Competitors

Table 19. Novartis Major Business

Table 20. Novartis COVID-19 Medicine Product and Solutions

Table 21. Novartis COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Sanofi Corporate Information, Head Office, and Major Competitors

Table 23. Sanofi Major Business

Table 24. Sanofi COVID-19 Medicine Product and Solutions

Table 25. Sanofi COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Apotex Corporate Information, Head Office, and Major Competitors

Table 27. Apotex Major Business

Table 28. Apotex COVID-19 Medicine Product and Solutions

Table 29. Apotex COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Bayer Corporate Information, Head Office, and Major Competitors

Table 31. Bayer Major Business

Table 32. Bayer COVID-19 Medicine Product and Solutions

Table 33. Bayer COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Guangzhou Baiyunshan Guanghua Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 35. Guangzhou Baiyunshan Guanghua Pharmaceutical Major Business

Table 36. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Product and Solutions

Table 37. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Ipca Laboratories Corporate Information, Head Office, and Major Competitors

Table 39. Ipca Laboratories Major Business

Table 40. Ipca Laboratories COVID-19 Medicine Product and Solutions

Table 41. Ipca Laboratories COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Sichuan Sunny Hope Corporate Information, Head Office, and Major Competitors

Table 43. Sichuan Sunny Hope Major Business

Table 44. Sichuan Sunny Hope COVID-19 Medicine Product and Solutions

Table 45. Sichuan Sunny Hope COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Zydus Cadila Corporate Information, Head Office, and Major Competitors

Table 47. Zydus Cadila Major Business

Table 48. Zydus Cadila COVID-19 Medicine Product and Solutions

Table 49. Zydus Cadila COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Teva Corporate Information, Head Office, and Major Competitors

Table 51. Teva Major Business

Table 52. Teva COVID-19 Medicine Product and Solutions

Table 53. Teva COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Sun Pharma Corporate Information, Head Office, and Major Competitors

Table 55. Sun Pharma Major Business

Table 56. Sun Pharma COVID-19 Medicine Product and Solutions

Table 57. Sun Pharma COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Rising Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 59. Rising Pharmaceutical Major Business

Table 60. Rising Pharmaceutical COVID-19 Medicine Product and Solutions

Table 61. Rising Pharmaceutical COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. KPC Group Corporate Information, Head Office, and Major Competitors

Table 63. KPC Group Major Business

Table 64. KPC Group COVID-19 Medicine Product and Solutions

Table 65. KPC Group COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Bristol Laboratories Corporate Information, Head Office, and Major Competitors

Table 67. Bristol Laboratories Major Business

Table 68. Bristol Laboratories COVID-19 Medicine Product and Solutions

Table 69. Bristol Laboratories COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Shanghai Zhongxisanwei Corporate Information, Head Office, and Major Competitors

Table 71. Shanghai Zhongxisanwei Major Business

Table 72. Shanghai Zhongxisanwei COVID-19 Medicine Product and Solutions

Table 73. Shanghai Zhongxisanwei COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Shanghai Pharma Corporate Information, Head Office, and Major Competitors

Table 75. Shanghai Pharma Major Business

Table 76. Shanghai Pharma COVID-19 Medicine Product and Solutions

Table 77. Shanghai Pharma COVID-19 Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Global COVID-19 Medicine Revenue (USD Million) by Players (2019-2021)

Table 79. Global COVID-19 Medicine Revenue Share by Players (2019-2021)

Table 80. Breakdown of COVID-19 Medicine by Company Type (Tier 1, Tier 2 and Tier 3)

Table 81. COVID-19 Medicine Players Head Office, Products and Services Provided

Table 82. COVID-19 Medicine Mergers & Acquisitions in the Past Five Years

Table 83. COVID-19 Medicine New Entrants and Expansion Plans

Table 84. Global COVID-19 Medicine Revenue (USD Million) by Type (2016-2021)

Table 85. Global COVID-19 Medicine Revenue Share by Type (2016-2021)

Table 86. Global COVID-19 Medicine Revenue Forecast by Type (2021-2026)

Table 87. Global COVID-19 Medicine Revenue by Application (2016-2021)

Table 88. Global COVID-19 Medicine Revenue Forecast by Application (2021-2026)

Table 89. North America COVID-19 Medicine Revenue by Type (2016-2021) & (USD Million)

Table 90. North America COVID-19 Medicine Revenue by Type (2021-2026) & (USD Million)

Table 91. North America COVID-19 Medicine Revenue by Application (2016-2021) & (USD Million)

Table 92. North America COVID-19 Medicine Revenue by Application (2021-2026) & (USD Million)

Table 93. North America COVID-19 Medicine Revenue by Country (2016-2021) & (USD Million)

Table 94. North America COVID-19 Medicine Revenue by Country (2021-2026) & (USD Million)

Table 95. Europe COVID-19 Medicine Revenue by Type (2016-2021) & (USD Million)

Table 96. Europe COVID-19 Medicine Revenue by Type (2021-2026) & (USD Million)

Table 97. Europe COVID-19 Medicine Revenue by Application (2016-2021) & (USD Million)

Table 98. Europe COVID-19 Medicine Revenue by Application (2021-2026) & (USD Million)

Table 99. Europe COVID-19 Medicine Revenue by Country (2016-2021) & (USD Million)

Table 100. Europe COVID-19 Medicine Revenue by Country (2021-2026) & (USD Million)

Table 101. Asia-Pacific COVID-19 Medicine Revenue by Type (2016-2021) & (USD Million)

Table 102. Asia-Pacific COVID-19 Medicine Revenue by Type (2021-2026) & (USD Million)

Table 103. Asia-Pacific COVID-19 Medicine Revenue by Application (2016-2021) & (USD Million)

Table 104. Asia-Pacific COVID-19 Medicine Revenue by Application (2021-2026) & (USD Million)

Table 105. Asia-Pacific COVID-19 Medicine Revenue by Region (2016-2021) & (USD Million)

Table 106. Asia-Pacific COVID-19 Medicine Revenue by Region (2021-2026) & (USD Million)

Table 107. South America COVID-19 Medicine Revenue by Type (2016-2021) & (USD Million)

Table 108. South America COVID-19 Medicine Revenue by Type (2021-2026) & (USD Million)

Table 109. South America COVID-19 Medicine Revenue by Application (2016-2021) & (USD Million)

Table 110. South America COVID-19 Medicine Revenue by Application (2021-2026) & (USD Million)

Table 111. South America COVID-19 Medicine Revenue by Country (2016-2021) & (USD Million)

Table 112. South America COVID-19 Medicine Revenue by Country (2021-2026) & (USD Million)

Table 113. Middle East & Africa COVID-19 Medicine Revenue by Type (2016-2021) & (USD Million)

Table 114. Middle East & Africa COVID-19 Medicine Revenue by Type (2021-2026) & (USD Million)

Table 115. Middle East & Africa COVID-19 Medicine Revenue by Application (2016-2021) & (USD Million)

Table 116. Middle East & Africa COVID-19 Medicine Revenue by Application (2021-2026) & (USD Million)

Table 117. Middle East & Africa COVID-19 Medicine Revenue by Country (2016-2021) & (USD Million)

Table 118. Middle East & Africa COVID-19 Medicine Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. COVID-19 Medicine Picture

Figure 2. Global COVID-19 Medicine Revenue Market Share by Type in 2020

Figure 3. Tablet

Figure 4. Injection

Figure 5. COVID-19 Medicine Revenue Market Share by Application in 2020

Figure 6. Patients With Mild Symptoms Picture

Figure 7. Critically Ill Picture

Figure 8. Other Picture

Figure 9. Global COVID-19 Medicine Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global COVID-19 Medicine Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global COVID-19 Medicine Revenue Market Share by Region (2016-2026)

Figure 12. Global COVID-19 Medicine Revenue Market Share by Region in 2020

Figure 13. North America COVID-19 Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe COVID-19 Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific COVID-19 Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America COVID-19 Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa COVID-19 Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. COVID-19 Medicine Market Drivers

Figure 19. COVID-19 Medicine Market Restraints

Figure 20. COVID-19 Medicine Market Trends

Figure 21. Advanz Pharma Recent Developments and Future Plans

Figure 22. Kyung Poong Recent Developments and Future Plans

Figure 23. Mylan Recent Developments and Future Plans

Figure 24. Novartis Recent Developments and Future Plans

Figure 25. Sanofi Recent Developments and Future Plans

Figure 26. Apotex Recent Developments and Future Plans

Figure 27. Bayer Recent Developments and Future Plans

Figure 28. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments and Future Plans

Figure 29. Ipca Laboratories Recent Developments and Future Plans

Figure 30. Sichuan Sunny Hope Recent Developments and Future Plans

Figure 31. Zydus Cadila Recent Developments and Future Plans

Figure 32. Teva Recent Developments and Future Plans

Figure 33. Sun Pharma Recent Developments and Future Plans

Figure 34. Rising Pharmaceutical Recent Developments and Future Plans

Figure 35. KPC Group Recent Developments and Future Plans

Figure 36. Bristol Laboratories Recent Developments and Future Plans

Figure 37. Shanghai Zhongxisanwei Recent Developments and Future Plans

Figure 38. Shanghai Pharma Recent Developments and Future Plans

Figure 39. Global COVID-19 Medicine Revenue Share by Players in 2020

Figure 40. COVID-19 Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 41. Global Top 3 Players COVID-19 Medicine Revenue Market Share in 2020

Figure 42. Global Top 10 Players COVID-19 Medicine Revenue Market Share in 2020

Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 44. Global COVID-19 Medicine Revenue Share by Type in 2020

Figure 45. Global COVID-19 Medicine Market Share Forecast by Type (2021-2026)

Figure 46. Global COVID-19 Medicine Revenue Share by Application in 2020

Figure 47. Global COVID-19 Medicine Market Share Forecast by Application (2021-2026)

Figure 48. North America COVID-19 Medicine Sales Market Share by Type (2016-2026)

Figure 49. North America COVID-19 Medicine Sales Market Share by Application (2016-2026)

Figure 50. North America COVID-19 Medicine Revenue Market Share by Country (2016-2026)

Figure 51. United States COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Canada COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Mexico COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Europe COVID-19 Medicine Sales Market Share by Type (2016-2026)

Figure 55. Europe COVID-19 Medicine Sales Market Share by Application (2016-2026)

Figure 56. Europe COVID-19 Medicine Revenue Market Share by Country (2016-2026)

Figure 57. Germany COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. France COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. United Kingdom COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Russia COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Italy COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Asia-Pacific COVID-19 Medicine Sales Market Share by Type (2016-2026)

Figure 63. Asia-Pacific COVID-19 Medicine Sales Market Share by Application (2016-2026)

Figure 64. Asia-Pacific COVID-19 Medicine Revenue Market Share by Region (2016-2026)

Figure 65. China COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Japan COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. South Korea COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. India COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Southeast Asia COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Australia COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. South America COVID-19 Medicine Sales Market Share by Type (2016-2026)

Figure 72. South America COVID-19 Medicine Sales Market Share by Application (2016-2026)

Figure 73. South America COVID-19 Medicine Revenue Market Share by Country (2016-2026)

Figure 74. Brazil COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Argentina COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Middle East and Africa COVID-19 Medicine Sales Market Share by Type (2016-2026)

Figure 77. Middle East and Africa COVID-19 Medicine Sales Market Share by Application (2016-2026)

Figure 78. Middle East and Africa COVID-19 Medicine Revenue Market Share by Country (2016-2026)

Figure 79. Turkey COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Saudi Arabia COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. UAE COVID-19 Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Methodology

Figure 83. Research Process and Data Source